| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1657.4B | ¥1656.0B | +0.1% |
| Operating Income | ¥149.2B | ¥248.6B | -40.0% |
| Ordinary Income | ¥169.9B | ¥268.6B | -36.7% |
| Net Income | ¥36.6B | ¥100.7B | -63.7% |
| ROE | 1.7% | 4.7% | - |
Fiscal year 2025 results: Revenue of 165.7B yen representing near-flat growth (+0.1% YoY), Operating Income of 14.9B yen (-40.0% YoY), Ordinary Income of 17.0B yen (-36.7% YoY), and Net Income of 3.7B yen (-63.7% YoY). The company manufactures and sells healthcare products, daily necessities, and heat pads through two reporting segments: Domestic and International. Revenue remained stable while profitability deteriorated significantly. The profit decline was primarily driven by substantial impairment losses of 14.8B yen recorded as extraordinary items, combined with increased selling, general and administrative expenses of 69.8B yen. Operating margin compressed from approximately 15.0% in the prior year to 9.0%, representing a 600 basis point deterioration. Despite the accounting profit decline, operating cash flow remained robust at 25.6B yen, resulting in an operating CF to net income ratio of 7.0x, indicating strong cash generation capability independent of temporary accounting charges.
Revenue of 165.7B yen increased marginally by 0.1% YoY, with Domestic segment sales declining 1.5% to 118.1B yen while International segment sales grew 4.0% to 47.0B yen. Within International sales, the US market expanded to 23.8B yen (+12.1% YoY), Southeast Asia reached 9.3B yen (+8.4% YoY), offsetting declines in China which decreased to 9.6B yen (-13.2% YoY). The Domestic segment accounts for 71.5% of total segment sales while International represents 28.5%, indicating a predominantly domestic-focused business model with gradual overseas expansion. Gross profit totaled 84.7B yen with selling, general and administrative expenses consuming 69.8B yen, resulting in operating income of 14.9B yen, down 40.0% YoY. The operating margin deterioration from approximately 15.0% to 9.0% reflects cost structure challenges, including advertising expenses of 13.5B yen. Non-operating income contributed a net positive 2.1B yen, comprising dividend income of 0.7B yen and interest income of 0.3B yen, bringing ordinary income to 17.0B yen. Extraordinary losses totaled 19.7B yen, primarily consisting of impairment losses of 14.8B yen, which substantially impacted net income. The gap between ordinary income of 17.0B yen and net income of 3.7B yen represents a 78% reduction attributable to these non-recurring charges. This exemplifies a revenue flat/profit down pattern, driven by compressed operating margins and significant extraordinary losses.
Domestic segment generated revenue of 122.9B yen with operating income of 14.0B yen, representing an operating margin of 11.4%. International segment recorded revenue of 48.4B yen with operating income of 0.8B yen, yielding a significantly lower operating margin of 1.7%. The Domestic segment remains the core business, accounting for 71.7% of total segment revenue and 94.5% of total segment operating profit. The dramatic margin differential of 970 basis points between Domestic (11.4%) and International (1.7%) highlights structural profitability challenges in overseas operations. Domestic operating profit declined 39.9% YoY from 23.2B yen to 14.0B yen despite only a 0.8% revenue decrease, indicating operating leverage deterioration. International operating profit decreased 36.3% YoY from 1.3B yen to 0.8B yen while revenue increased 3.4%, suggesting margin compression amid growth investment. The substantial profit decline in the core Domestic segment represents the primary drag on consolidated profitability, warranting management attention to cost structure optimization.
[Profitability] ROE of 1.7% reflects substantial deterioration driven by net profit margin compression to 2.2%, combined with total asset turnover of 0.60x and financial leverage of 1.30x. Operating margin of 9.0% represents a 600 basis point contraction from the prior year's approximately 15.0%, primarily attributable to increased SG&A expenses and extraordinary impairment charges. EBITDA totaled 22.3B yen with an EBITDA margin of 13.4%. [Cash Quality] Cash and deposits of 62.3B yen provide 10.4x coverage of short-term debt, indicating exceptionally strong liquidity. Operating cash flow of 25.6B yen relative to net income of 3.7B yen yields a 7.0x ratio, demonstrating high-quality cash-backed earnings despite accounting profit suppression. [Investment Efficiency] Asset turnover of 0.60x reflects capital-intensive operations. Fixed asset turnover stands at 1.88x. Construction in progress of 17.7B yen represents 26.2% of total fixed assets, indicating significant ongoing capital deployment. Capital expenditure of 13.3B yen represents 1.80x depreciation, signaling growth-oriented investment activity. [Financial Health] Equity ratio of 76.7% demonstrates conservative capital structure. Current ratio of 247.5% and quick ratio of 223.0% indicate robust short-term liquidity. Debt-to-equity ratio of 0.30x reflects minimal leverage. Interest coverage ratio of 533x provides substantial debt service cushion.
Operating cash flow of 25.6B yen represents 7.0x net income, confirming strong cash generation capability independent of temporary accounting charges. The substantial divergence between operating CF and net income primarily reflects the add-back of non-cash impairment losses of 14.8B yen. Investing cash flow of negative 0.2B yen comprised capital expenditures of 13.3B yen offset by proceeds from investment activities. Free cash flow of 25.4B yen demonstrates the company's ability to fund both growth investments and shareholder returns. Working capital efficiency deteriorated with days sales outstanding extending to 115 days and days inventory outstanding at 66 days, resulting in a cash conversion cycle of 179 days. This represents a concerning trend in operational efficiency despite strong headline cash flow figures. The company maintains ample cash reserves of 62.3B yen alongside investment securities of 31.8B yen, providing total liquid assets of 94.1B yen, well in excess of near-term obligations and supporting financial flexibility.
Ordinary income of 17.0B yen compared to operating income of 14.9B yen shows a net non-operating contribution of approximately 2.1B yen. This primarily comprises dividend income of 0.7B yen and interest income of 0.3B yen, representing financial income from the company's substantial cash and investment portfolio. Non-operating income represents 1.3% of revenue, consisting of recurring investment returns. The material divergence between ordinary income of 17.0B yen and net income of 3.7B yen stems from extraordinary losses of 19.7B yen, of which impairment losses constitute 14.8B yen. These non-recurring charges represent 466% of net income, indicating substantial one-time impacts on reported profitability. Operating cash flow of 25.6B yen exceeds net income of 3.7B yen by 7.0x, reflecting the add-back of non-cash charges and validating underlying earnings quality. However, working capital metrics show concerning trends with DSO at 115 days and DIO at 66 days, suggesting operational efficiency challenges that warrant monitoring despite strong cash generation.
Full-year forecast projects revenue of 173.0B yen (+4.4% vs current period), operating income of 12.5B yen (-16.2% YoY), ordinary income of 13.0B yen (-23.5% YoY), and net income of 10.0B yen. The guidance anticipates revenue recovery with continued operating profit pressure. Operating income guidance of 12.5B yen represents only 8.4% of forecast revenue, indicating management expects structural margin challenges to persist. The forecast net income of 10.0B yen substantially exceeds current period net income of 3.7B yen, primarily reflecting the expected absence of the 14.8B yen impairment charge. Current period results represent 95.8% progress on revenue, 119.3% on operating income, and 36.6% on net income versus full-year forecast, with the operating income overachievement suggesting guidance may require revision. The net income shortfall reflects the severity of extraordinary charges recorded. Forecast assumptions include dividend per share of 45 yen and EPS of 134.52 yen, implying approximately 74 million shares outstanding.
Annual dividend of 104.0 yen comprised interim dividend of 43.0 yen and year-end dividend of 59.0 yen. The calculated payout ratio of 217.8% based on reported net income appears unsustainably high, though this calculation is distorted by the extraordinary impairment charges that temporarily suppressed accounting profits. Free cash flow of 25.4B yen provides 3.2x coverage of dividends, indicating the dividend is well-supported by operating cash generation independent of accounting earnings. The XBRL-reported payout ratio of 0.8% suggests alternative calculation methodology or data classification differences requiring clarification. Despite net income volatility, the company's strong operating cash flow of 25.6B yen and substantial cash reserves of 62.3B yen support dividend sustainability in the near term. Management's forecast dividend of 45 yen represents a reduction from the current period's 104.0 yen, potentially reflecting normalization of payout policy aligned with expected earnings recovery, though this warrants further explanation given the substantial year-over-year decrease.
Structural profitability deterioration: Operating margin compressed 600 basis points to 9.0% with Domestic segment operating profit declining 39.9% despite minimal revenue decrease, indicating fundamental cost structure challenges. SG&A expenses of 69.8B yen represent 42.1% of revenue, suggesting limited operating leverage and potential margin pressure persistence.
Working capital efficiency degradation: Days sales outstanding of 115 days, days inventory outstanding of 66 days, and cash conversion cycle of 179 days represent substantial deterioration in operational efficiency. Extended receivables collection and inventory turnover strain cash generation despite strong operating CF, creating vulnerability to demand shocks.
International segment margin weakness: International operations generate only 1.7% operating margin versus 11.4% domestically, with absolute operating profit of merely 0.8B yen on 48.4B yen revenue. Continued overseas expansion at current profitability levels risks diluting consolidated returns and consuming capital without adequate returns, particularly given China market contraction of 13.2% YoY and ongoing market uncertainties.
(Industry Position) (Reference - Proprietary Analysis) The company demonstrates conservative financial positioning with an equity ratio of 76.7% substantially above typical industry capital structures, reflecting minimal leverage utilization. Operating margin of 9.0% has declined from historical levels of approximately 15.0%, now tracking below the company's recent performance trajectory. The 0.1% revenue growth significantly lags industry growth expectations, indicating market share challenges or category headwinds. ROE of 1.7% represents substantial deterioration from the company's historical range, reflecting both profitability compression and conservative balance sheet management. Working capital metrics show concerning trends with cash conversion cycle of 179 days suggesting operational efficiency below industry standards for consumer products manufacturers. The company's net profit margin of 2.2% is temporarily suppressed by extraordinary charges but indicates underlying margin pressure even before one-time items. Investment intensity with capital expenditure at 1.80x depreciation suggests growth investment commitment though return visibility requires monitoring. The company's historical dividend payout ratio averaged approximately 75% prior to current period volatility, indicating established shareholder return commitment. Current period metrics reflect transitional challenges with structural profitability requiring management attention to restore competitive positioning.
Operating cash flow resilience: Despite a 63.7% decline in reported net income, operating cash flow remained robust at 25.6B yen, representing 7.0x net income coverage. This divergence highlights the temporary nature of the 14.8B yen impairment charge while validating underlying business cash generation capability. Free cash flow of 25.4B yen provides substantial capacity for dividends, capital investment, and strategic initiatives independent of accounting earnings volatility.
Core business profitability deterioration: The Domestic segment, representing 71.7% of revenue and 94.5% of operating profit, experienced a 39.9% operating profit decline on minimal revenue decrease, signaling fundamental margin compression beyond temporary factors. Operating margin contraction of 600 basis points company-wide reflects structural cost challenges requiring operational restructuring. Management guidance projects further operating income decline of 16.2% next year despite 4.4% revenue growth, indicating margin pressure persistence.
Balance sheet strength with capital deployment questions: Equity ratio of 76.7%, current ratio of 247.5%, and cash plus investment securities totaling 94.1B yen demonstrate conservative financial positioning. However, construction in progress of 17.7B yen (26.2% of fixed assets) combined with international segment operating margins of only 1.7% raises questions regarding capital deployment effectiveness and return on invested capital, particularly as working capital efficiency deteriorates with 179-day cash conversion cycle warranting management focus on operational excellence alongside growth investment.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.